Department of Obstetrics and Gynaecology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer (2022) Ramachandran D, Dennis J, Fachal L, Schurmann P, Bousset K, Huelse F, Mao Q, et al. Journal article Role of Fiber Thickness and Surface Treatment of Electrospun Polycaprolactone Matrices on the Growth of Different Breast Cancer‐Associated Cells (2022) Sivakumar S, Schmid R, Wieland A, Strissel P, Strick R, Fischer L, Thievessen I, et al. Journal article Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review (2022) Huang M, Haiderali A, Fox GE, Frederickson A, Cortes J, Fasching P, O'Shaughnessy J Journal article, Review article ABC6 Consensus: Assessment by a Group of German Experts (2022) Lueftner D, Fasching P, Haidinger R, Harbeck N, Jackisch C, Mueller V, Schumacher-Wulf E, et al. Journal article Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy (2022) Beckmann M, Stübs F, Koch M, Mallmann P, Dannecker C, Dietl A, Sevnina A, et al. Journal article Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia) (2022) Hein A, Kehl S, Häberle L, Tiemann C, Peuker R, Mereutanu D, Stumpfe F, et al. Journal article Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities (2022) Fehm T, Stübs F, Koch M, Mallmann P, Dannecker C, Dietl A, Sevnina A, et al. Journal article Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer—findings from the RIBECCA trial (2022) Peuker CA, Yaghobramzi S, Grunert C, Keilholz L, Gjerga E, Hennig S, Schaper S, et al. Journal article Pregnant and Postpartum Women Requiring Intensive Care Treatment for COVID-19—First Data from the CRONOS-Registry (2022) Sitter M, Pecks U, Rüdiger M, Friedrich S, Malfertheiner SF, Hein A, Königbauer JT, et al. Journal article Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial (2022) Gerber B, Schneeweiss A, Möbus V, Golatta M, Tesch H, Krug D, Hanusch C, et al. Journal article